FLGT - Fulgent Genetics Non-GAAP EPS of $0.78 revenue of $125.34M
- Fulgent Genetics press release ( NASDAQ: FLGT ): Q2 Non-GAAP EPS of $0.78.
- Revenue of $125.34M.
- Outlook:
- Raises full year core revenue outlook to $185 million from previously announced $180 million.
- Total Revenue of approximately $665 million. Consensus Revenue Estimate for 2022 $649.60M.
- Non-GAAP income of approximately $6.00 per share. Consensus EPS Estimate for 2022 is $6.23
- Q3 Outlook:
- Total Revenue of approximately $105 million. Consensus Revenue Estimate for Q3 is $106.30M.
- Core Revenue of approximately $54 million, representing growth of 101% year-over-year.
For further details see:
Fulgent Genetics Non-GAAP EPS of $0.78, revenue of $125.34M